–
Allogene Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−180
FY22:
−336
FY23:
−328
FY24:
−273
FY25:
−209
(positive)
Change from FY21 to FY22
millions USD
FY21:
−170
FY22:
−321
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−257
FY22:
−340
FY23:
−327
FY24:
−257
FY25:
−191
(positive)
Change from FY21 to FY25
millions USD
FY21:
−182
FY22:
−340
FY23:
−327
FY24:
−258
FY25:
−191
All amounts in millions USD